Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Recro Pharma, Inc. | 1,049,287 | reported | 08 Apr 2024 | tx 90+2,355,452−1,822,606 |
| LIFECORE BIOMEDICAL, INC. \DE\ | 336,691 | reported | 03 Sept 2025 | tx 10+1,182,220−170,529 |
| Baudax Bio, Inc. | 69,251 | reported | 15 Jan 2021 | tx 12+262,929−48,292 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 03 Sept 2025 | TAX_WITHHOLDING | LIFECORE BIOMEDICAL, INC. \DE\ | 22,932 | 7.71 USD | |
| 08 Jul 2025 | EXERCISE | LIFECORE BIOMEDICAL, INC. \DE\ | 75,000 | — | |
| 08 Jul 2025 | TAX_WITHHOLDING | LIFECORE BIOMEDICAL, INC. \DE\ | 32,806 | 8.19 USD | |
| 08 Jul 2025 | EXERCISE | LIFECORE BIOMEDICAL, INC. \DE\ | 75,000 | — | deriv |
| 06 Dec 2024 | TAX_WITHHOLDING | LIFECORE BIOMEDICAL, INC. \DE\ | 5,653 | 7.15 USD | |
| 06 Dec 2024 | GRANT_AWARD | LIFECORE BIOMEDICAL, INC. \DE\ | 19,720 | 0.00 USD | |
| 07 Oct 2024 | EXERCISE | LIFECORE BIOMEDICAL, INC. \DE\ | 75,000 | — | |
| 07 Oct 2024 | TAX_WITHHOLDING | LIFECORE BIOMEDICAL, INC. \DE\ | 34,138 | 5.09 USD | |
| 03 Sept 2024 | GRANT_AWARD | LIFECORE BIOMEDICAL, INC. \DE\ | 262,500 | — | |
| 03 Sept 2024 | GRANT_AWARD | LIFECORE BIOMEDICAL, INC. \DE\ | 750,000 | 0.00 USD | deriv |
| 08 Apr 2024 | TENDER | Recro Pharma, Inc. | 522,699 | 1.10 USD | |
| 08 Apr 2024 | OTHER | Recro Pharma, Inc. | 1,049,287 | 1.10 USD | |
| 29 Feb 2024 | GRANT_AWARD | Recro Pharma, Inc. | 771,429 | 0.00 USD | |
| 03 Feb 2024 | TAX_WITHHOLDING | Recro Pharma, Inc. | 1,022 | 0.45 USD | |
| 24 Jan 2024 | GRANT_AWARD | Recro Pharma, Inc. | 110,025 | 0.00 USD | |
| 24 Jan 2024 | TAX_WITHHOLDING | Recro Pharma, Inc. | 37,453 | 0.35 USD | |
| 19 Jan 2024 | TAX_WITHHOLDING | Recro Pharma, Inc. | 19,654 | 0.35 USD | |
| 20 Jan 2024 | TAX_WITHHOLDING | Recro Pharma, Inc. | 14,442 | 0.35 USD | |
| 02 Jan 2024 | TAX_WITHHOLDING | Recro Pharma, Inc. | 1,419 | 0.41 USD | |
| 15 Dec 2023 | TAX_WITHHOLDING | Recro Pharma, Inc. | 5,690 | 0.37 USD | |
| 30 Nov 2023 | TAX_WITHHOLDING | Recro Pharma, Inc. | 1,197 | 0.37 USD | |
| 31 Oct 2023 | TAX_WITHHOLDING | Recro Pharma, Inc. | 1,198 | 0.34 USD | |
| 30 Sept 2023 | TAX_WITHHOLDING | Recro Pharma, Inc. | 1,198 | 0.46 USD | |
| 31 Aug 2023 | TAX_WITHHOLDING | Recro Pharma, Inc. | 1,197 | 0.57 USD | |
| 31 Jul 2023 | TAX_WITHHOLDING | Recro Pharma, Inc. | 1,198 | 0.85 USD |